‘Immune Archetypes:’ New Approach to Immunotherapies
UCSF Researchers Uncover Common Immune Microenvironments Across Different Types of Cancer
Exai Bio Launches Big in Series A Financing
Next-generation liquid biopsy company based on the University of California, San Francisco’s technologies developed in Dr. Hani Goodarzi’s laboratory, raised $67.5 million. Goodarzi is also a 2018 Catalyst Awardee.
The Truth About UCSF Innovation
OTMA Executive Director Anthony Francis opens up about MedTech innovation and using the academic institution as a launchpad for startups.
Congratulation to Peter Kotsonis, our new Assistant Vice Chancellor
Strategic Alliances leader, Peter Kotsonis has been promoted to “Assistant Vice Chancellor of Business Development, Innovation, and Partnerships”.
Catalyst Awardees Win the Harrington Innovator-Scholar Award
Jennifer Chen and John Chorba, two UCSF Catalyst awardees, win the 2021 Harrington Innovator-Scholar Award for projects that also won the Catalyst Award.
Helping Paralyzed Man "Speak"
In a medical first, researchers, led by Dr. Edward Chang, harnessed the brain waves of a man paralyzed and unable to speak for 15 years - and turned his thoughts into sentences on a computer screen.

Who We Are

Translational technology development and commercialization is a complex process because every project is unique. Innovation Ventures is dedicated to helping the UCSF community navigate those complexities by working up-close with our research faculty and promising students to really understand their science. We have a single purpose and that is to support the transition of UCSF innovation out of the lab and into the marketplace as more fully developed therapies, with a greater confidence of success. Whether evaluating a new discovery, securing funding, seeking external partnerships, or starting new companies, Innovation Ventures is here to facilitate protection, development, and commercialization of novel and valuable healing inventions.

From Innovation...